首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
【24h】

Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.

机译:携带质粒介导的喹诺酮抗性决定簇的临床肺炎克雷伯菌和大肠杆菌分离株之间的表型和基因型特征多样。

获取原文
获取原文并翻译 | 示例
           

摘要

A total of 59 and 74 nonduplicate plasmid-mediated quinolone resistance (PMQR) genes-carrying Klebsiella pneumoniae and Escherichia coli isolates were collected. All strains were assayed for fluoroquinolone susceptibility and the prevalence of quinolone resistance-determining regions (QRDRs) mutation. The association between PMQR determinants and common beta-lactamase genes was also analyzed. Genetic relatedness of the isolates was analyzed by pulsed-field gel electrophoresis (PFGE). The PMQR genes-carrying K. pneumoniae and E. coli isolates exhibited high fluoroquinolone resistance rates, indicating that PMQR determinants play an essential role in the development of fluoroquinolone resistance. Remarkably, most qnr-carrying strains had only a single or no QRDR mutation in GyrA or ParC, and most exhibited decreased ciprofloxacin (CIP) susceptibility or low-level CIP resistance. However, 71.4% and 98.4% of qnr-negative K. pneumoniae and E. coli contained double QRDR mutations, and most presented high-level CIP resistance. Additionally, K. pneumoniae presented a lower CIP resistance rate than E. coli (59.3% vs. 91.9%) and low carriage of double QRDR mutations (38.9% vs. 89.9%). Also, most (88.1%) K. pneumoniae examined in this study carried qnr and only 14.9% of E. coli were qnr positive. Thus, the high fluoroquinolone susceptibility of K. pneumoniae isolates is primarily due to fewer QRDR substitutions as a result of high prevalence of qnr alleles in the host. Our findings support the hypothesis that chromosomal resistance mutations could be affected by the presence of Qnr, in other words, Qnr may protect the QRDR domains in the gyrase and topoisomerase IV from mutations under the inhibition of fluoroquinolones. Another remarkable finding was that the PMQR genes-carrying K. pneumoniae exhibited much higher proportions of extended-spectrum beta-lactamases (ESBLs)-positive phenotype than E. coli (73.5% vs. 59.5%). This is due to not only the high prevalence of SHV-type ESBL-conferring enzymes in K. pneumoniae but also the interference of DHA-producing K. pneumoniae as a result of the strong association between qnrB and bla(DHA).
机译:总共收集了59和74个携带肺炎克雷伯菌和大肠杆菌的非重复质粒介导的喹诺酮耐药性(PMQR)基因。分析所有菌株的氟喹诺酮敏感性和喹诺酮耐药性决定区(QRDRs)突变的发生率。还分析了PMQR决定簇与常见β-内酰胺酶基因之间的关联。分离物的遗传相关性通过脉冲场凝胶电泳(PFGE)进行分析。携带PMQR基因的肺炎克雷伯菌和大肠杆菌分离株表现出较高的氟喹诺酮耐药率,这表明PMQR决定簇在氟喹诺酮耐药性的发展中起着至关重要的作用。值得注意的是,大多数携带qnr的菌株在GyrA或ParC中仅具有单个或没有QRDR突变,并且大多数表现出环丙沙星(CIP)敏感性降低或CIP抵抗力低下。但是,qnr阴性的肺炎克雷伯菌和大肠杆菌中有71.4%和98.4%包含双QRDR突变,并且大多数表现出高水平的CIP耐药性。此外,肺炎克雷伯菌的CIP耐药率比大肠杆菌低(59.3%对91.9%),双QRDR突变携带率低(38.9%对89.9%)。同样,在这项研究中检查的大多数(88.1%)肺炎克雷伯菌带有qnr,只有14.9%的大肠杆菌是qnr阳性。因此,肺炎克雷伯菌分离株的高氟喹诺酮敏感性主要是由于宿主中qnr等位基因的高流行导致较少的QRDR取代。我们的发现支持以下假设,即Qnr的存在可能会影响染色体耐药性突变,换句话说,Qnr可以保护回旋酶和拓扑异构酶IV中的QRDR结构域免受氟喹诺酮类药物的抑制。另一个引人注目的发现是,携带PMQR基因的肺炎克雷伯氏菌比大肠埃希氏菌具有更高比例的广谱β-内酰胺酶(ESBLs)阳性表型(73.5%vs. 59.5%)。这不仅是由于qnrB与bla(DHA)之间有很强的关联性,而且在肺炎克雷伯氏菌中,SHV型赋予ESBL的酶普遍存在,而且是产生DHA的肺炎克雷伯菌的干扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号